Energy Balance, Host-Related Factors, and Cancer Progression

被引:191
作者
Hursting, Stephen D. [1 ]
Berger, Nathan A.
机构
[1] Univ Texas Austin, Austin, TX 78712 USA
基金
美国国家卫生研究院;
关键词
GROWTH-FACTOR-I; RESTRICTION-INDUCED INHIBITION; TUBEROUS SCLEROSIS COMPLEX; IGF-BINDING PROTEIN-3; LIFE-SPAN EXTENSION; BREAST-CANCER; COLON-CANCER; CALORIE RESTRICTION; METABOLIC SYNDROME; PROSTATE-CANCER;
D O I
10.1200/JCO.2010.27.9935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Obesity is associated with an increased risk and worsened prognosis for many types of cancer, but the mechanisms underlying the obesity-cancer progression link are poorly understood. Several energy balance-related host factors are known to influence tumor progression and/or treatment responsiveness after cancer develops, and these have been implicated as key contributors to the complex effects of obesity on cancer outcome. These host factors include leptin, adiponectin, steroid hormones, reactive oxygen species associated with inflammation, insulin, insulin-like growth factor-1, and sirtuins. Each of these host factors is considered in this article in the context of energy balance and cancer progression. In addition, future research directions in this field are discussed, including the importance of study designs addressing energy balance across the life course, the development and application of highly relevant animal models, potential roles of cancer stem cells in the response to energy balance modulation, and emerging pharmacologic approaches that target energy balance-related pathways.
引用
收藏
页码:4058 / 4065
页数:8
相关论文
共 140 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[3]   A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk [J].
Allen, NE ;
Roddam, AW ;
Allen, DS ;
Fentiman, IS ;
Silva, ID ;
Peto, J ;
Holly, JMP ;
Key, TJ .
BRITISH JOURNAL OF CANCER, 2005, 92 (07) :1283-1287
[4]  
*AM I CANC RES WOR, FOOD NUTR PHYS ACT P
[5]   SIRT1: Linking adaptive cellular responses to aging-associated changes in organismal physiology [J].
Anastasiou, Dimitrios ;
Krek, Wilhelm .
PHYSIOLOGY, 2006, 21 :404-410
[6]   Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae [J].
Anderson, RM ;
Bitterman, KJ ;
Wood, JG ;
Medvedik, O ;
Sinclair, DA .
NATURE, 2003, 423 (6936) :181-185
[7]   Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease [J].
Astrinidis, A ;
Henske, EP .
ONCOGENE, 2005, 24 (50) :7475-7481
[8]   Adiponectin in relation to malignancies: a review of existing basic research and clinical evidenced [J].
Barb, Diana ;
Williams, Catherine J. ;
Neuwirth, Anke K. ;
Mantzoros, Christos S. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (03) :858S-866S
[9]   OBESITY AS AN ADVERSE PROGNOSTIC FACTOR FOR PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER [J].
BASTARRACHEA, J ;
HORTOBAGYI, GN ;
SMITH, TL ;
KAU, SWC ;
BUZDAR, AU .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) :18-25
[10]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506